A detailed history of Signaturefd, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 652 shares of ARWR stock, worth $12,361. This represents 0.0% of its overall portfolio holdings.

Number of Shares
652
Previous 506 28.85%
Holding current value
$12,361
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$19.36 - $29.54 $2,826 - $4,312
146 Added 28.85%
652 $12,000
Q2 2024

Jul 29, 2024

BUY
$21.87 - $28.24 $6,495 - $8,387
297 Added 142.11%
506 $13,000
Q1 2024

May 03, 2024

BUY
$27.21 - $39.48 $2,149 - $3,118
79 Added 60.77%
209 $5,000
Q4 2023

Jan 31, 2024

BUY
$21.2 - $31.03 $445 - $651
21 Added 19.27%
130 $3,000
Q3 2023

Nov 03, 2023

BUY
$26.2 - $36.08 $2,305 - $3,175
88 Added 419.05%
109 $2,000
Q2 2023

Aug 01, 2023

SELL
$25.16 - $41.38 $603 - $993
-24 Reduced 53.33%
21 $0
Q1 2023

Apr 28, 2023

SELL
$23.68 - $38.51 $6,227 - $10,128
-263 Reduced 85.39%
45 $1,000
Q4 2022

Jan 27, 2023

SELL
$28.0 - $40.56 $4,032 - $5,840
-144 Reduced 31.86%
308 $12,000
Q3 2022

Nov 08, 2022

BUY
$29.63 - $48.31 $6,044 - $9,855
204 Added 82.26%
452 $15,000
Q2 2022

Aug 10, 2022

BUY
$27.79 - $50.61 $6,086 - $11,083
219 Added 755.17%
248 $9,000
Q1 2022

May 02, 2022

SELL
$39.62 - $69.97 $3,843 - $6,787
-97 Reduced 76.98%
29 $1,000
Q4 2021

Jan 25, 2022

BUY
$58.09 - $82.51 $348 - $495
6 Added 5.0%
126 $8,000
Q3 2021

Oct 28, 2021

SELL
$58.38 - $84.96 $1,809 - $2,633
-31 Reduced 20.53%
120 $7,000
Q2 2021

Jul 26, 2021

SELL
$62.15 - $90.32 $1,367 - $1,987
-22 Reduced 12.72%
151 $13,000
Q1 2021

Apr 30, 2021

BUY
$61.35 - $90.47 $5,092 - $7,509
83 Added 92.22%
173 $11,000
Q4 2020

Feb 11, 2021

BUY
$43.82 - $85.37 $1,139 - $2,219
26 Added 40.63%
90 $7,000
Q3 2020

Nov 03, 2020

BUY
$33.21 - $51.27 $730 - $1,127
22 Added 52.38%
64 $3,000
Q2 2020

Jul 30, 2020

BUY
$26.12 - $43.27 $1,097 - $1,817
42 New
42 $2,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.01B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.